ElevateBio said on Wednesday it had raised $401 million in a new funding round led by a fund run by Matrix Capital Management, as the venture capital market looks to stage a rebound following a dreary 2022.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com